Cargando…
YKL-40 as a possible marker of neutrophilic asthma
Asthma is a heterogeneous chronic disorder of the airways, with inflammation and bronchial hyperresponsiveness as its major underlying phenomena. Asthmatics vary in terms of inflammation pattern, concomitant pathologies, and factors aggravating the course of the disease. As a result, there is a need...
Autores principales: | Specjalski, Krzysztof, Romantowski, Jan, Niedoszytko, Marek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945318/ https://www.ncbi.nlm.nih.gov/pubmed/36844232 http://dx.doi.org/10.3389/fmed.2023.1115938 |
Ejemplares similares
-
YKL-40 correlates with the phenotype of asthma
por: Specjalski, Krzysztof, et al.
Publicado: (2015) -
YKL-40 Protein Correlates with the Phenotype of Asthma
por: Specjalski, Krzysztof, et al.
Publicado: (2015) -
IFNG, FCER1A, PCDHB10 expression as a new potential marker of efficacy in grass pollen allergen-specific immunotherapy
por: Romantowski, Jan, et al.
Publicado: (2021) -
Smoking history is negatively associated with allergen specific immunotherapy efficacy: a retrospective analysis
por: Romantowski, Jan, et al.
Publicado: (2019) -
Serum YKL-40 Levels in Patients with Asthma or COPD: A Pilot Study
por: Popețiu, Romana Olivia, et al.
Publicado: (2023)